NASDAQ | ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index.
The index is designed to provide exposure toU. S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 8.84% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 7.15% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 6.98% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 6.93% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 6.66% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 4.54% |
| CAH | Cardinal Health Inc | Healthcare | Medical Distribution | 4.41% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 3.81% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.68% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.62% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 3.51% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 3.16% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 3.09% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.70% |
| OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 2.65% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.29% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 2.15% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 1.86% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.66% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 1.62% |